Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer
Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The proposed study aims to investigate how the administration of a drug known to reduce
inflammation in humans, Celecoxib, will effect the peri-operative inflammatory response of a
patient undergoing primary tumor resection surgery for colon cancer. The proposed project is
an exploratory study, and will use data from blood samples and tumor samples to attempt to
elucidate the immune and inflammatory response in colon cancer patients undergoing primary
resection of their tumors.